Statins and outcomes in patients with pneumonia: not only healthy user bias.
作者信息
Mortensen Eric M, Restrepo Marcos I, Copeland Laurel A, Pugh Mary Jo V, Anzueto Antonio
出版信息
BMJ. 2006 Nov 25;333(7578):1123-4. doi: 10.1136/bmj.39038.509167.1F.
Abstract
摘要
相似文献
1
Statins and outcomes in patients with pneumonia: not only healthy user bias.他汀类药物与肺炎患者的预后：不仅仅是健康使用者偏差。
BMJ. 2006 Nov 25;333(7578):1123-4. doi: 10.1136/bmj.39038.509167.1F.
2
Statins and outcomes in patients with pneumonia: appreciating bias and precision in study.他汀类药物与肺炎患者的预后：认识研究中的偏倚与精准度
BMJ. 2006 Nov 25;333(7578):1124. doi: 10.1136/bmj.39038.515521.1F.
3
Statins and outcomes in patients with pneumonia: not the best combination.他汀类药物与肺炎患者的预后：并非最佳组合。
BMJ. 2006 Nov 25;333(7578):1124. doi: 10.1136/bmj.39038.505012.1F.
4
Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study.他汀类药物与社区获得性肺炎住院患者的预后：基于人群的前瞻性队列研究
BMJ. 2006 Nov 11;333(7576):999. doi: 10.1136/bmj.38992.565972.7C. Epub 2006 Oct 23.
5
The lesser known effects of statins: benefits on infectious outcomes may be explained by "healthy user" effect.他汀类药物鲜为人知的作用：对感染性结局的益处可能由“健康使用者”效应来解释。
BMJ. 2006 Nov 11;333(7576):980-1. doi: 10.1136/bmj.39024.513218.BE.
6
What is the real role of statins in community-acquired pneumonia and sepsis?他汀类药物在社区获得性肺炎和脓毒症中真正的作用是什么？
Crit Care Med. 2011 Aug;39(8):1998-2000. doi: 10.1097/CCM.0b013e31821f02a8.
7
Understanding the potential role of statins in pneumonia and sepsis.了解他汀类药物在肺炎和脓毒症中的潜在作用。
Crit Care Med. 2011 Aug;39(8):1871-8. doi: 10.1097/CCM.0b013e31821b8290.
8
The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia.既往使用他汀类药物对社区获得性肺炎住院患者30天死亡率的影响。
Respir Res. 2005 Jul 25;6(1):82. doi: 10.1186/1465-9921-6-82.
9
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia.他汀类药物和血管紧张素转换酶抑制剂对肺炎住院患者死亡率的影响。
Eur Respir J. 2008 Mar;31(3):611-7. doi: 10.1183/09031936.00162006. Epub 2007 Oct 24.
10
Statins in community acquired pneumonia: Evidence from experimental and clinical studies.社区获得性肺炎中的他汀类药物：来自实验和临床研究的证据。
Respir Med. 2010 Aug;104(8):1081-91. doi: 10.1016/j.rmed.2010.04.005. Epub 2010 May 5.
引用本文的文献
1
Statin Use in Relation to COVID-19 and Other Respiratory Infections: Muscle and Other Considerations.他汀类药物的使用与新冠病毒病及其他呼吸道感染的关系：肌肉及其他考量因素
J Clin Med. 2023 Jul 13;12(14):4659. doi: 10.3390/jcm12144659.
2
The effect of statin therapy on the incidence of infections: a retrospective cohort analysis.他汀类药物治疗对感染发生率的影响：一项回顾性队列分析。
Am J Med Sci. 2014 Mar;347(3):211-6. doi: 10.1097/MAJ.0b013e31828318e2.
本文引用的文献
1
Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study.他汀类药物与社区获得性肺炎住院患者的预后：基于人群的前瞻性队列研究
BMJ. 2006 Nov 11;333(7576):999. doi: 10.1136/bmj.38992.565972.7C. Epub 2006 Oct 23.
2
The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia.既往使用他汀类药物对社区获得性肺炎住院患者30天死亡率的影响。
Respir Res. 2005 Jul 25;6(1):82. doi: 10.1186/1465-9921-6-82.
3
Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study.社区获得性肺炎患者的死亡原因：肺炎患者预后研究团队队列研究的结果
Arch Intern Med. 2002 May 13;162(9):1059-64. doi: 10.1001/archinte.162.9.1059.
4
A prediction rule to identify low-risk patients with community-acquired pneumonia.一种用于识别社区获得性肺炎低风险患者的预测规则。
N Engl J Med. 1997 Jan 23;336(4):243-50. doi: 10.1056/NEJM199701233360402.
Zotero 插件